Aesica plans £3m high potency expansion

By Gareth Macdonald

- Last updated on GMT

Related tags: High potency, Pharmacology

Aesica will build a “high containment” manufacturing plant to expand its high potency drug formulation capabilities in line with growing demand.

The £3m ($4.6m) facility, at the UK contract manufacturing organisation’s (CMO) site in Queenborough, Kent, will produce, package and ship both liquid and solid dosage forms when fully operational in summer 2011.

A company spokeswoman told Outsourcing-pharma the plant will give Aesica “greater service provision​” and confirmed that it will cater for customers worldwide.

This echoed comments by commercial director Adam Sims who said within drug industry “the use of more potent compounds has made high containment drug manufacturing a key focus for customers outsourcing their products​.”

Aescia is one of a number of CMOs to have invested in high potency handling and manufacturing capacity in recent years. Notable examples include SAFC, Patheon and Catalent.

Schedule II boost

In addition to housing capacity for potent active pharmaceutical ingredients (API) and intermediates, the new plant will be one of only a handful in the UK capable of making Schedule II controlled drugs.

This capability further strengthens Aesica’s position in the sector, which received a significant boost after its facility in Cramlington, Northumberland was cleared to make Schedule II compounds last year

Expansion efforts

Aesica’s new investment fits with comments Sims during an interview with in-pharmatechnologist in February​, when he explained that consolidating the firm’s position in Europe was a key business goal.

Prior to today’s announcement, Aesica had already begun strengthening its formulations business with the acquisition​ of fellow UK-based company R5 Pharmaceuticals.

Related news

Show more

Related products

show more

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers

Follow us


View more